Life Sciences Archive » September, 2008

Life Sciences - September, 2008

120 articles

• P&G Hits Teva With New Actonel Suit
• AstraZeneca Sues Accord Over Seroquel
• 2 Classes Certified In Drug Pricing Suit
• Abbott Unit's Injunction Bid Denied In Stent Spat
• Judge Throws Out Philips Defibrillator Patent Suit
• Biocare Wins Bid To Drop AsymmetRx Patent Suit
• Judge Certifies Class In ERISA Suit Against Schering
• No Inequitable Conduct In $41M Lens Suit: Judge
• Fruit Of The Earth Settles Coppertone Sunblock Suit
• FDA Strengthens Medtronic Catheter Recall Status
• Eli Lilly Sues Teva Again Over Gemzar ANDA
• Willfulness Claim Struck In Suit Over Xopenex
• Cephalon Finalizes $425M Deal Over Off-Label Claims
• Iovate Settles Supplement Patent Suit
• Ex-Exec Allegedly Faked Cancer To Avoid SEC
• Pfizer Chief Litigation Counsel Joins Morgan Lewis
• Biotech Settles False Claims Charges
• Leaps & Bounds: Notable Firm News
• Judge Axes Some Sham Litigation Claims Over TriCor
• CVS Workers Call For Review In FLSA Case
• Judge Boots Bristol-Myers False Claims Suit
• Vultures Circle As Heller Ehrman Set To Break Apart
• Zyprexa MDL Judge Orders States To Produce Docs
• CryoCath, Boston Scientific Unit Settle Patent Spat
• Roche Amends Boniva Suits Against Teva
• Shire's Adderall Patent Suit To Go On
• Warranty Claims Shaved From 1st Seroquel Trials
• Judge Chides Defendants In Restoril Patent Suit
• Teva's Judgment Bid Nixed In Pulmicort Case
• Tying Case Against Amgen Voluntarily Dismissed
• Bayer May Be Liable For Texas Superfund Site
• Medtronic, Abbott Fight For Judgment In Stent Feud
• FDA Yanks Eyewash, Skin Cream Over Side Effects
• Bayer Sues Sandoz, Watson Over Another Yaz Patent
• Sepracor, UMass Sue Over Liquid Clarinex ANDA
• No Quick Win For Corepharma In Epilepsy Drug Fight
• Amgen's Enbrel Does Not Infringe Ariad Patent: Judge
• Hospitals Partially Win Catheter Co. Antitrust Class
• Firms Circling Heller Ehrman Practices: Report
• Roxane Settles Price Inflation Suit For $1.8M
• Judge Pools Drugstore Antitrust Cases Against AmEx
• Invitrogen Hit With Suit Over Semiconductor Patents
• Antitrust Practice: Dechert LLP
• Stem Cell Patent Invalid: Consumer Watchdogs
• Judge Splits Difference In Pfizer Discovery Dispute
• Medical Device Ads Scrutinized By Senate Panel
• Judge Denies Sanctions Against States, Lilly In MDL
• FDA's Hearing On Allergen Advisory Labeling
• House Committee Widens Ranbaxy Probe
• J&J Unit Resolves Monistat Suit Against Perrigo
• Ranbaxy Banks On Giuliani Amid FDA Drug Ban
• Supreme Court Hears High Stakes Liability Cases
• Longs Shakes Head At Walgreens' $3B Buyout Bid
• FDA Bars Ranbaxy Drugs For Manufacturing Violations
• EC Approves Teva's Generic Version Of Neupogen
• BMS Sues Abbott Over Baby Formula Container Patent
• GSK Wants USPTO Appeals Board Ruling Overturned
• W.L. Gore Wins Judgment In Aneurysm Patent Feud
• GSK's Curbs On Parallel Trading May Be Illegal: Court
• CoolTouch Hits Back At VNUS Over Laser Patents
• Judge Reinstates $595M Award In Cordis Patent Suit
• Fresenius Reaches Accord With FTC Over Anemia Drug
• Roche, Cobalt Drop Claims Over One Boniva Patent
• Wyeth's Vitamin Ads Draw Scrutiny From House Panel
• Carnegie Mellon: A Key Ruling For Biotech Patents
• Teva Seeks To Bar FDA Approval Of Risperdal ANDAs
• Knobbe Lures Patent Litigator From Foley & Lardner
• Medtronic Recalls Fatally Flawed Defibrillators
• Fen-Phen Plaintiff Denied Cut Of Settlement
• Lilly, States Quarrel Over Zyprexa Discovery
• Ferring Looks To Chop Down Direct Purchaser Suits
• EPA Fines Pharma For Wastewater Violations
• Recent DOJ, FTC Spat Highlights Long-Running Rift
• Slot-Machine Patent Doesn't Reinvent Wheel: Judge
• VNUS Sues Bankrupt Rival Over Vein Surgery Patents
• FDA Considers Reclassifying Hemostatic Devices
• San Francisco Tobacco Rule Biased, Walgreen Claims
• Abbott To Pay $28M To Settle Texas Medicaid Suit
• GSK Seeks Final Approval For $40M Paxil Settlement
• Mylan Loses Bid To Dismiss Arthritis Drug Suit
• Longs Drug Stores Strikes Deal In CVS Merger Suits
• 5th Circ. Upholds Dismissal Of Cyberonics Class Action
• 3rd Circ. Revives Vioxx Securities Suit
• Institut Pasteur Tries To Block New Novartis Theory
• Fungal Settlements Reached In Contact Lens MDL
• Merck Misled USPTO In Singulair Patent Case: Teva
• University Of Iowa Claims Amgen Infringed Patents
• Appeals Ruling Ends 14-Year DNA Patent Case
• Retractable Sues To Protect Syringe Patents
• 3rd-Party Payer Class Certified In Zyprexa MDL
• Judge Gives Preliminary Approval To Par Settlement
• Judge Won't Push Back Fen-Phen Lawyers' Trial
• Suit Claims Ford Hid Faulty Truck Engines
• CardioFocus Seeks 2nd Settlement In Patent Spat
• Preparing A Witness For A Successful Deposition
• La. Seeks Sanctions Against Eli Lilly In Zyprexa MDL
• Pfizer's Reconsideration Bid Nixed In Securities Suit
• Barr Fires Back At Celgene In Thalomid Patent Case
• Pregnancy Test Patent Nixed In 10-Year Fight
• Md. Appeals Court Affirms Lilly Car Crash Ruling
• Apotex Loses Appeal In Risperdal Patent Fight
• Judge Denies GSK Plea To Drop Paxil Suicide Case
• Lawyers Question FDA's Changes To Labeling Rules
• Hi-Tech Sues FDA To Get Generic Cosopt Exclusivity
• Privacy Of Genetic Info And GINA In An Electronic Age
• FDA Demands Stronger Warnings For TNF-Blockers
• The Evolving Declaratory Judgment Standard
• Family Says Formula Caused Baby's Meningitis
• Teva Sues Sandoz, Novartis Over Copaxone ANDA
• Analyst Predicts Black Box Warning For Byetta
• Amended ANDA Triggers Another Detrol Complaint
• Teva Sues Glenmark In Latest Suit Over Generic Coreg
• Breckenridge Sues KV In Vitamin Patent Dispute
• Signalife Slapped With Securities Class Action
• Telik Settles Securities Class Action For $5M
• Purdue Pharma Strikes Licensing Deal For OxyContin
• GSK Sues Lupin Over ANDA For HIV Drug Combivir
• Suspicions Persist Over Vytorin's Cancer Risk
• Medtronic Can Add Claims, But Stent Trial Bumped
• States Face Calls For Sanctions In Zyprexa MDL